comparemela.com

Page 10 - Atacand Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca (LON:AZN) Shares Pass Above 200-Day Moving Average of $10,602 86

AstraZeneca PLC (LON:AZN – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of £106.03 ($134.79) and traded as high as £106.14 ($134.94). AstraZeneca shares last traded at £105.68 ($134.35), with a volume of 2,345,376 shares trading hands. Wall Street Analyst […]

AstraZeneca PLC (NASDAQ:AZN) Position Lifted by Addison Advisors LLC

Addison Advisors LLC raised its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 46.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 730 shares of the company’s stock after purchasing an additional 232 shares during the period. Addison Advisors LLC’s holdings in AstraZeneca were worth $49,000 […]

Addison Advisors LLC Buys 232 Shares of AstraZeneca PLC (NASDAQ:AZN)

Addison Advisors LLC raised its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 46.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 730 shares of the company’s stock after acquiring an additional 232 shares during the period. Addison Advisors LLC’s holdings in […]

VELA Investment Management LLC Has $892,000 Position in AstraZeneca PLC (NASDAQ:AZN)

VELA Investment Management LLC grew its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 16.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,177 shares of the company’s stock after purchasing an additional 1,881 shares during the quarter. VELA Investment […]

AstraZeneca PLC (LON:AZN) Receives £118 95 Consensus PT from Analysts

Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have received an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.